Quality Specifications for the Determination of Copper, Zinc, and Selenium in Human Serum or Plasma: Evaluation of an Approach Based on Biological and Analytical Variation

Abstract

Background: Trace element external quality assessment schemes monitor laboratory performance and provide a stimulus for improvement in accuracy. However, monitoring of participant performance varies according to the scheme and can lead to conflicting conclusions. Methods: Quality specifications based on biological intra- and interindividual variability were calculated and compared to those currently used by various trace element external quality assessment schemes for plasma or serum copper, zinc, and selenium concentrations. For this purpose, we evaluated results reported by participating laboratories in different schemes, at key concentrations, using z scores. Results: Minimal quality specifications developed from the biological intra- and interindividual variability were, for Cu, ±0.84 μmol/L or 12% of the assigned target concentration, whichever is greater; for Zn, ±1.20 μmol/L or 15% of the assigned target concentration, whichever is greater; and for Se, ±0.072 μmol/L or 12% of the assigned target concentration, whichever is greater. Reported performance of the participating laboratories depended on analyte, concentration, and the selected quality specification. In addition, the most commonly used methods for the determination of Cu, Zn, and Se may give different results. Conclusions: The proposed minimal quality specifications based on biological variation are generally slightly less stringent than those currently in use, although they do not drastically change the performance evaluation in the different schemes. These specifications are a first step in the harmonization of practices among the schemes and remain to be evaluated.

Hedgehog Pathway Antagonist 5E1 Binds Hedgehog at the Pseudo-active Site

“…Because the extracellular physiological concentrations of 1.3 mM Ca 2ϩ and 12-17 M Zn 2ϩ (45,46) exceed their respective K D values for Shh of ϳ100 M (11) and Ͻ100 pM (47), the two Shh cation-binding sites are likely fully occupied under physiological conditions and are thus unlikely to regulate Shh activity in vivo or affect 5E1 activity in a therapeutic setting. In addition, in studies using 5E1 in a Hh-expressing xenograft model of colorectal cancer, efficacious doses of 5E1 result in serum levels of 5E1 that are over 1000-fold higher than the K D for Shh for up to a week (Ref.…”

Measuring zinc on the Roche cobas c502 analyzer—Validation, comparison, and pre‐analytic aspects

“…Arnaud et al 32 defined minimum quality specifications for the determination of zinc concentrations in human serum or plasma, where <5% bias was defined as optimal relative bias. As such, the bias estimated for the LT-SYS copper assay on a Roche cobas c502 analyzer can well be categorized under the optimal quality specification as defined by Arnaud et al 32 The LT-SYS zinc assay proved to be linear over the tested measuring range from 1.15 to 34.7 μmol/L (7.51 to 226.9 μg/dL), thus covering the full range from pathological low, to pathological high zinc higher on average. This difference is somewhat compensated by the assay specific reference intervals given by the suppliers, where Wako…”

Traceable assigned values in external quality assessment schemes compared to those obtained by alternative procedure: a case study for Cu, Se and Zn in serum

“…In a separate study of EQA schemes for measurements of Al in serum, the robust means from different schemes were signicantly different, as indicated by the Z-scores. 12 A number of possible explanations may be advanced as causing a bias. In some schemes the participants are more likely to be specialist trace element centres while in other schemes the prole may be biased towards general clinical laboratories.…”